. 2016 Jan 14;5(1):41–46. doi: 10.1530/EC-15-0118
This work is licensed under a Table 1.
Clinical and biochemical features of IGHD and control subjects.
| IGHD (25) | Control (27) | P | |
|---|---|---|---|
| Age (years) | 50.1 (15.9) | 51.1 (14.0) | 0.799 |
| Sex (F/M) | 13/12 | 15/12 | 0.764 |
| Smoking | 1 | 2 | 1 |
| Weight (kg) | 39.3 (8.7) | 71.8 (14.4) | <0.0001 |
| Diabetes history | 4 | 2 | 0.411 |
| Dislipidemia history | 11 | 11 | 1 |
| Arterial hypertension | 8 | 16 | 0.058 |
| Height (m) | 1.2 (0.18) | 1.6 (0.1) | <0.0001 |
| BMI (kg/m2) | 25.5 (5.7) | 26.7 (4.2) | 0.402 |
| Systolic BP (mmHg) | 122.1 (18.9) | 124.4 (15.0) | 0.622 |
| Diastolic BP (mmHg) | 78.8 (9.3) | 80.4 (6.5) | 0.486 |
| IGF1 (ng/ml) | 1.9 (0) | 132 (55) | <0.0001 |
| Glucose (mg/dl) | 105.5 (22.7) | 105.9 (70.5) | 0.975 |
| Insulin (mUI/ml) | 5.35 (3.8) | 17.3 (10.9) | <0.0001 |
| Homa IR | 1.4 (1.0) | 4.3 (3.1) | 0.012 |
| Cholesterol (mg/dl) | 227.0 (65.1) | 210.7 (28.2) | 0.257 |
| Tryglicerides (mg/dl) | 142.0 (95.5) | 135.3 (51.3) | 0.762 |
| Urea (mg/dl) | 38.6 (9.8) | 34.7 (9.0) | 0.143 |
| Creatinine (mg/dl) | 0.7 (0.1) | 0.9 (0.2) | <0.0001 |
| Creatininekinase (IU/l) | 82.0 (35.1) | 152.8 (141.0) | 0.017 |
| Framingham score | 5.7 (6.4) | 4.9 (4.5) | 0.596 |